UCaize
Shanghai
About UCaize
UCaize is a biopharmaceutical company that researches and develops novel medications for the treatment of blood cancers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $11.0M
- Funding stage: Seed
- Last round: Seed (Feb 2025)
Industries & Categories
Biopharma, Health Care, Medical
Canonical: https://fsome.com/organization/ucaize-11969 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.